alpha-aminopyridine has been researched along with AIDS-Associated Nephropathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, PY; Deng, Y; He, JC; Klotman, PE; Liu, R; Mallipattu, SK; Wu, Y; Zhong, Y | 1 |
| Ray, PE | 1 |
2 other study(ies) available for alpha-aminopyridine and AIDS-Associated Nephropathy
| Article | Year |
|---|---|
Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure.
Topics: AIDS-Associated Nephropathy; Aminopyridines; Animals; Benzamides; Benzoates; Cell Differentiation; CREB-Binding Protein; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclopropanes; Cytoprotection; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Kidney Tubules; Male; Mice; Mice, Transgenic; Phosphodiesterase 4 Inhibitors; Phosphorylation; Proteinuria; Receptors, Retinoic Acid; Renal Insufficiency; Retinoic Acid Receptor alpha; Signal Transduction; Tetrahydronaphthalenes; Time Factors | 2012 |
Can we cure HIV-1-associated nephropathy in transgenic mice?
Topics: AIDS-Associated Nephropathy; Aminopyridines; Animals; Benzamides; Benzoates; Cyclopropanes; Female; HIV Infections; HIV-1; Kidney Tubules; Male; Phosphodiesterase 4 Inhibitors; Renal Insufficiency; Tetrahydronaphthalenes | 2012 |